Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Latest Information Update: 09 Sep 2019
Price :
$35 *
At a glance
- Drugs Ranolazine (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- Acronyms RWISE
- 22 Dec 2016 Results of retrospective tissue tracking analysis assessing systolic/diastolic strain, using cardiac magnetic resonance imaging cine images acquired from RWISE trial (n=128) and healthy reference controls (n=43), published in the Clinical Cardiology.
- 18 Oct 2016 Status changed from recruiting to completed.
- 02 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Jan 2018.